Page 1

Live Webinar

on

Challenges that must be Considered When First-in-Human and Subsequent Phase I studies are Contemplated

Date & Time: Tuesday, March 6, 2012

10:00 AM PST | 01:00 PM EST

Duration: 90 Minutes

Instructor: Charles H Pierce

Location: Online

Price : $245.00

 

Register Now

(for one participant)

Instructor Profile:

Overview:

Charles H Pierce Consultant, Clinical Research / Drug-Device Development,

This Webinar goes over the scientific standards of the First-in-Human ("first-in-Man" / FIM) studies and other Phase I studies in the drug development process. The FiM and other Phase I studies set the tone of all future Pre NDA studies. It is in Phase I where the eventual safe clinical dosage range is defined as well as how the body handles the drug in the normal situation, When there is compromised organ of elimination function, in the fasted and fed states as well as carefully looking at the possibility of major drug interactions. As expected the safety of the drug in human subjects is the backbone of Phase I investigations. The most critical study is the FiM where it is imperative that the dosage started with has been carefully selected so that toxicity is nil or absent. Among the many challenges we face is that no longer: l

Is the First-in-Man study only done on normal healthy volunteers.

l

Are protocols fixed lines in the sand that are not changeable until the study ends. Is the New Chemical Entity (NCE) a simple chemical with

l

l

predictable effects. Do we see Phase I studies conducted only in confined Clinical Pharmacology Units.

Charles H. Pierce, MD, PhD, FCP, CPI is a consultant in the Clinical Research / Drug-Device Development arena specializing in bringing the message of GCP Regulations and Investigator Responsibility to the entire investigative team to help them understand the regulations as well as the ethics of research involving human subjects. Dr. Pierce serves as an advisor to several clinical research organizations, sits on industry based boards, and is VP of Medical Affairs for Harrison Clinical Research GmbH, a global CRO headquartered in Munich. He has been in the Clinical Research Industry for 20 years, has been involved in developing Phase I & IIa Clinical Pharmacology Units, Investigator and staff GCP training, and medical monitoring in both drug and device studies. ...more

Areas Covered in the Session: l

What is the roll of the Investigators Brochure in the FiM process?

l

What do you expect to learn from the FiM study? What are the factors in choosing the first does of a NCE The challenge of developing an effective / efficient Phase I Program

l l

l

l

l l

l

How to recruit Study Participants in this new age of Social Media The importance of accurately assessing and reporting Adverse Events The importance of Protocol knowledge in preventing errors How to not miss "safety Assessments" when you do not know what to look for The Setting up of a site that is prepared for First-in-man studies

Click here to register for this webinar Who Will Benefit: l

Principal Investigators and sub investigators

l

Clinical Research Scientists Research Managers Safety Nurses

l l l l l l l

Clinical Research Associates (CRAs) and Coordinators (CRCs) Recruiting Staff QA / QC auditors and staff Study Monitors Clinical Research Data managers

Suggest a Topic

More Webinars

Your Necessity is our Priority


It would be really nice if you can circulate this mail to all your deserving colleagues who can immensely benefit from this program. For more information, please contact the event coordinator. We look forward to seeing you at the webinar. Best regards, Event-coordinator GlobalCompliancePanel

About GlobalCompliancePanel GlobalCompliancePanel is an online knowledge fulfillment community portal & it has put together a new model for online compliance training by creating a single window of learning opportunities for compliance professionals & providing a forum for expert speakers/panelists to render their services through simplified online training delivery mechanisms. Our commitment is give compliance regulatory training, showcasing of best industry practices & quality enrichment training sessions in a most cost effective manner. Compliance professionals can benefit from a wide range of training sessions, giving a diverse choice of events & all sessions being either Live or recorded stream or in the form of audio CDs. GlobalCompliancePanel portal ensures a secure & cost effective online environment and also support your E-learning and development on/through our website. Keep track of all webinars arranged for your industry through notifications & event calendars being mailed to your inbox. GlobalCompliancePanel opens new doors of learning opportunities for professionals. GlobalCompliancePanel www.globalcompliancepanel.com 1000 N West Street Suite, 1200 Wilmington DE 19801 Phone: 800-447-9407 or Fax your PO to: 302-288-6884 If you do not wish to receive this training alerts from GlobalCompliancePanel Click Unsubscribe

Challenges that must be Considered When First-in-Human andSubsequent Phase I  

This Webinar goes over the scientific standards of the First-in-Human ("first-in-Man" / FIM) studies and other Phase I studies in the drug d...

Read more
Read more
Similar to
Popular now
Just for you